Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    14729632 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors
Conditions: Brain Stem Neoplasms;   Glioma;   Pinealoma
Interventions: Drug: IMC-A12;   Drug: Temsirolimus

Indicates status has not been verified in more than two years